The prevalence of hepatitis C in survivors of paediatric malignancy
- PMID: 9259300
- DOI: 10.1111/j.1440-1754.1997.tb01587.x
The prevalence of hepatitis C in survivors of paediatric malignancy
Abstract
Objective: To assess the prevalence of hepatitis C in 200 patients with paediatric malignancies, surviving in remission more than 5 years from diagnosis, who had received blood product transfusions before 1990 when routine screening of blood products for hepatitis C began.
Method: The second and third generation Abbott Diagnostics ELISA was used to assess hepatitis C seropositivity. Seropositive patients and those with abnormal liver transaminases were assessed by hepatitis C virus RNA polymerase chain reaction (PCR).
Results: A low incidence (4%) of seropositivity for hepatitis C was found in survivors of paediatric malignancy who were transfused prior to routine screening of blood products in this cohort.
Conclusions: All patients identified have evidence of hepatitis and may be at high risk of developing cirrhosis.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
